ロード中...
Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
BACKGROUND: Immune thrombocytopenia (ITP) in dogs is analogous to that in humans. Romiplostim, a novel thrombopoietin receptor (TPO-R) agonist, is currently used for the treatment of refractory ITP in humans, but not in dogs. Here, we describe the response to romiplostim in five dogs with refractory...
保存先:
| 出版年: | BMC Vet Res |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4901510/ https://ncbi.nlm.nih.gov/pubmed/27283401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-016-0718-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|